CD8A and neoplasm: Intraperitoneal immunisation with a synthetic peptide incorporating Antp and OVA CD8 epitope was shown to generate potent CTL responses and protective immunity in vivo against the growth of the OVA expressing tumour cell line E.G7-OVA [14].